PLoS ONE (Jan 2012)

Hypertension in women of reproductive age in the United States: NHANES 1999-2008.

  • Brian T Bateman,
  • Kate M Shaw,
  • Elena V Kuklina,
  • William M Callaghan,
  • Ellen W Seely,
  • Sonia Hernández-Díaz

DOI
https://doi.org/10.1371/journal.pone.0036171
Journal volume & issue
Vol. 7, no. 4
p. e36171

Abstract

Read online

To examine the epidemiology of hypertension in women of reproductive age.Using NHANES from 1999-2008, we identified 5,521 women age 20-44 years old. Hypertension status was determined using blood pressure measurements and/or self-reported medication use.The estimated prevalence of hypertension in women of reproductive age was 7.7% (95% confidence interval (CI): 6.9%-8.5%). The prevalence of anti-hypertensive pharmacologic therapy was 4.2% (95% CI 3.5%-4.9%). The prevalence of hypertension was relatively stable across the study period; the age and race adjusted odds of hypertension in 2007-2008 did not differ significantly from 1999-2000 (odds ratio 1.2, CI 0.8 to 1.7, p = 0.45). Significant independent risk factors associated with hypertension included older age, non-Hispanic black race (compared to non-Hispanic whites), diabetes mellitus, chronic kidney disease, and higher body mass index. The most commonly used antihypertensive medications included diuretics, angiotensin-converting enzyme inhibitors (ACE), and beta blockers.Hypertension occurs in about 8% of women of reproductive age. There are remarkable differences in the prevalence of hypertension between racial/ethnic groups. Obesity is a risk factor of particular importance in this population because it affects over 30% of young women in the U.S., is associated with more than 4 fold increased risk of hypertension, and is potentially modifiable.